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Abstract
Background: Physical activity has proven to be beneficial for physical functioning, cognition, depression, anxiety,
rest-activity rhythm, quality of life (QoL), activities of daily living (ADL) and pain in older people. The aim of this
study is to investigate the effect of walking regularly on physical functioning, the progressive cognitive decline,
level of depression, anxiety, rest-activity rhythm, QoL, ADL and pain in older people with dementia.
Methods/design: This study is a longitudinal randomized controlled, single blind study. Ambulatory older people
with dementia, who are regular visitors of daily care or living in a home for the elderly or nursing home in the
Netherlands, will be randomly allocated to the experimental or control condition. Participants of the experimental
group make supervised walks of 30 minutes a day, 5 days a week, as part of their daily nursing care. Participants of
the control group will come together three times a week for tea or other sedentary activities to control for
possible positive effects of social interaction. All dependent variables will be assessed at baseline and after 6 weeks,
and 3, 6, 9, 12 and 18 months of intervention.
The dependent variables include neuropsychological tests to assess cognition, physical tests to determine physical
functioning, questionnaires to assess ADL, QoL, level of depression and anxiety, actigraphy to assess rest-activity
rhythm and pain scales to determine pain levels. Potential moderating variables at baseline are: socio-demographic
characteristics, body mass index, subtype of dementia, apolipoprotein E (ApoE) genotype, medication use and
comorbidities.
Discussion: This study evaluates the effect of regular walking as a treatment for older people with dementia. The
strength of this study is that 1) it has a longitudinal design with multiple repeated measurements, 2) we assess
many different health aspects, 3) the intervention is not performed by research staff, but by nursing staff which
enables it to become a routine in usual care. Possible limitations of the study are that 1) only active minded
institutions are willing to participate creating a selection bias, 2) the drop-out rate will be high in this population,
3) not all participants will be able to perform/understand all tests.
Trial registration: NTR1482
Background
Aging may coincide with a decline in the level of physical
activity [1]. This age-related decline in physical activity is
often related to difficulties in physical performances, e.g.
walking and getting out of a chair [2,3]. There is ample
evidence that in cognitively intact older people living in
the community or in long-term care, physical performance
can be enhanced by physical activity interventions [4-10].
It is suggested that the intensity of the intervention is posi-
tively related to its effectiveness, i.e. a higher intensity pro-
duces a higher effect [11]. Nursing home residents are
sometimes considered as too frail or too cognitively
impaired to benefit from physical activity interventions,
but cognitively impaired people seem to benefit from phy-
sical activity interventions just as much as cognitively
intact people [7]. Furthermore, it has been suggested that
frail dependent people only benefit from frequent indivi-
dualised interventions, while less frail people already
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respond positively to traditional group interventions [12].
Other studies, including residents with and without cogni-
tive impairment [7,10] or only people with cognitive
impairment [11,13-16], confirmed that all residents can
improve physical performances through physical activity,
but evidence of high-quality studies is still limited or
inconclusive.
The risk of dementia might be reduced by physical activ-
ity due to its positive effect on cognition [4,17-21], espe-
cially on executive functions (EF) [18,21]. When people
already show a cognitive decline or suffer from dementia,
which highly affects cognition due to neuropathology [22],
results on the effects of exercise on cognition are equivocal
[13,14]. An explanation for not finding a beneficial cogni-
tive effect was that the interventions mainly consisted of
strength-, balance- and/or flexibility-based exercises [14].
A recent meta-analysis indicated that the evidence is not
sufficient for firm conclusions about the effectiveness of
physical activity interventions on cognition in dementia
[23]. The evidence that is available is promising since exer-
cise has a large effect on cognition (Cohen’s d = 1.31) and
was observed as being significantly different from the con-
trol group (moderate effect: Cohen’s d = 0.56 and 0.57)
[16,24]. More research is warranted, because the available
studies differ in exercise protocols, durations and outcome
measures [14,23].
One of the risk factors for dementia is an increased level
of anxiety and/or depression [25]. In healthy older people
physical activity interventions can increase mental health,
e.g. self-esteem, happiness and mood [4,26]. Looking expli-
citly at depression and anxiety, physical activity interven-
tions can reduce the depressive symptoms within 3 months
in older people with a depression [27] or anxiety after 3
weeks in people with a chronic physical condition, e.g.
fibromyalgia [28]. Long-term effects of exercise on depres-
sive symptoms and anxiety remain to be demonstrated in
clinical trials [4,27]. Even though physical activity as a
treatment for depression may be as effective as medication,
it is currently under-used for this disorder despite having
many additional health benefits, for example a reduced risk
of heart disease, stroke, high blood pressure, some cancers,
type 2 diabetes, osteoporosis and obesity [27]. This makes
a physical activity treatment appropriate for older people
with a combination of physical and mental health problems
such as dementia [27]. In people with dementia evidence of
helping with depression is limited [11,23], but the results of
available studies are promising [13,14].
Together with a rising level of depression and cognitive
impairment, the prevalence and frequency of sleep disor-
ders in long term care residents is increasing [29]. More
than half of the residents suffer from some kind of sleep
disorder [29]. Night-time wakefulness can lead to
increased daytime sleeping and vice versa [30]. Sleep dis-
orders and a lack of activities negatively influence each
other [29]. Long-term care residents spend extended per-
iods of time in bed and are sedentary during the daytime,
which contributes to abnormal circadian rhythms, i.e.
rest-activity rhythm [30]. In older persons with or with-
out dementia, a physical activity intervention seems to be
effective [24,31-34], especially in people with poor sleep
at baseline [33]. These studies, however, are scarce since
the majority of physical activity intervention studies are
multi-dimensional, i.e. physical activity is combined with
bright light or a decrease in noise at night [24,30,31,33].
Such a combination hampers the understanding of which
intervention is (most) effective [35]. A disturbance in the
rest-activity rhythm is one of the prominent clinical
symptoms in people with dementia which should be
recognized and enhanced, since it has a high impact on
the quality of life (QoL) [31].
QoL is determined by many aspects in life, e.g. quality
and quantity of sleep [36], cognitive functioning [36] and
level of depressive symptoms [37]. Exercise programs can
slow down the decline in QoL in older community dwell-
ing people [38] and in a combined resident group of peo-
ple with and without dementia [39]. However, for a group
including only people with dementia the evidence for an
effect on QoL due to physical activity is limited [11,13,23].
QoL is also affected when people with dementia lose the
ability to cope with the physical activities of daily life
(ADL), e.g. eating, bathing, using the toilet, dressing, walk-
ing and continence [40]. Due to participation in a physical
activity intervention, a combined resident group of people
with and without dementia can prevent or reduce a
decline in ADL compared to a control group [12,39]. In
groups with only older people with dementia, there is
some evidence that physical activity can improve the abil-
ity to cope with ADL [16,41], but there were not sufficient
studies for a meta-analysis to conclude whether or not
physical activity could be effective for ADL performance
in people with dementia [13,23].
The risk to decline in ADL performance increases by
approximately 20% for each (additional) painful part of the
body, i.e. the neck, back, hands, hips, knees or feet [42]. In
older people pain is often caused by the musculoskeletal
condition of the joints [43]. In cognitively intact older peo-
ple a dose-response relationship exists between the level of
physical activity and pain; a higher physical activity level
was related to less stiff and painful joints [43] and people
experienced less pain during a cancer treatment when they
performed more aerobic exercises, e.g. walking [44]. In
addition, there is more evidence that pain can be reduced
by stretching activities [45] or resistance training [46] and
specifically (low) back pain by resistance, agility or stretch-
ing activities [46]. In contrast, a moderate-intensity endur-
ance and strengthening program had no effect on pain in
healthy elderly [45] and neither had a 12 weeks walking
program in older people with dementia [47]. No other
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studies including people with dementia examined the effect
of physical activity on pain even though this is necessary
since pain is often under-diagnosed and under-treated in
people with dementia [48,49].
Studies related to older people with (or without)
dementia have not been able to reach a consensus on the
types and intensity of the exercise, nor the frequency and
duration of the intervention to be most effective and effi-
cient [14]. This is due to the variety in outcome mea-
sures; one outcome measure can respond faster to a
physical activity intervention than another outcome mea-
sure [14]. The effect on outcome measures is also depen-
dent on the age of participants, the cognitive impairment
and frailty level [14]. However, in both frail and non-frail
older adults regular exercise is the only therapy found to
consistently improve health aspects, e.g. physical func-
tion, cognitive performance and mood [4]. Most meta-
analyses and reviews have concluded that longitudinal
randomized controlled trials (RCT) are of vital impor-
tance [4,9,10,12-14,18-20,50,51]. Especially people with
more severe cognitive impairment should be included in
future research [14]. As mentioned above, physical activ-
ity has proven to be beneficial to improve or slow down
many health aspects in older people with dementia. The
aim of the present study is therefore to investigate longi-
tudinally the effect of regular walking on physical func-
tioning, cognition, level of depression and anxiety, rest-
activity rhythm, QoL, ADL and pain in older people with
dementia.
Methods/design
Participants
Participants are older mobile people with dementia who
are visiting day care or living in a home for the elderly or
nursing home in the Netherlands. Inclusion criteria are 1)
a diagnosis of dementia or presence of cognitive impair-
ment that is reported in the medical status and 2) ambula-
tory with or without walking aid (walker or cane).
Exclusion criteria are the presence of personality disorders,
cerebral traumata, hydrocephalus, neoplasm, disturbances
of consciousness and focal brain disorders.
Study design and randomization
This study is a RCT. Participants will be randomly
divided into the intervention or control group. In order
to preclude that the effects arise only from the intensified
social contacts during intervention, the control group
within a residency will come together three times a week
for tea or other sedentary activities, e.g. watching televi-
sion. The Medical Ethical Committee of VU university
medical center approved the study. Oral and written
informed consent will be obtained from all participants
or their relevant relatives prior to their enrolment.
Intervention
The intervention consist of a daily 30 minute walk, 5 times
a week under supervision of an assistant, e.g. medical staff,
volunteers or family members. Depending on the partici-
pant, the assistant, the living area and the weather, the
intervention can take place in the morning or afternoon,
inside or outside, during midweek and/or weekends. Each
day the participant has walked will be carefully noted,
together with the time of day, duration and whether it was
inside or outside.
Sample size
Sample size calculation was performed using the statistical
power analysis program G*Power 3.1 [52] which has the
possibility to perform power analyses for a repeated mea-
sures design with a between group variable. Based on two
meta-analyses studying the effect of physical activity on
cognition [16,24], the estimated effect size in this study is
expected to be moderate to large (Cohens f = 0.32). Using
a type 1 error of 0.05, a power of 0.80, seven repeated
measurements and 2 groups, a sample size of 70 in each
group is required. Taking into account an attrition rate of
25%, 175 participants should be included in this study.
Recruitment
Participants for this study will be recruited via medical
staff of aged care facilities. First, the medical staff will be
informed about the goal and procedure of the study. Sec-
ondly, possible participants will be selected within subu-
nits of the institutions by a team, including the researcher,
medical staff and nurses. Third, an information letter with
informed consent will be sent to the legal representatives
of the participants, together with an invitation to attend an
oral presentation. Fourth, once written consent is received,
subunits make a schedule for assistants to accompany the
regular walks of participants in the intervention group.
Procedure
The outcome variables are measured at baseline (pre-treat-
ment: T0), after 6 weeks of intervention (post-treatment:
T1) and after 3 (T2), 6 (T3), 9 (T4), 12 (T5) and 18 (T6)
months of intervention. Trained experimenters, blinded to
the intervention assignment, will administer the neuropsy-
chological tests, physical tests and level of depression, anxi-
ety and pain. The nursing staff fills in questionnaires to
measure QoL, ADL and define the stage of dementia. The
other variables are objective measurements.
Characteristics
Characteristics include age, gender, subtype of dementia,
type of living situation, i.e. independently in society, in a
home for the elderly or in a nursing home as well as the
following aspects:
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Highest education level
The highest education level will be determined on a seven-
point scale with 1 = less than elementary school, 2 = 6
grades of elementary school, 3 = 7 or 8 grades of elemen-
tary school, 4 = 3 years of lower general secondary educa-
tion, 5 = 4 years of lower general secondary education, 6 =
pre-university education and higher vocational education,
7 = university and technical college [53].
Body mass index (BMI)
BMI is calculated as weight in kilograms divided by
height in meters squared.
Apolipoprotein E (ApoE) genotype
ApoE type 4 allele (ApoE4) plays a major role in cerebral
perfusion and metabolism and is a known risk factor for
late onset Alzheimer’s disease (AD) [54]. In addition,
ApoE4 carriers show different effects on cognition as a
result of some therapy than non-carriers [55,56]. In view
of this possible moderating effect on treatment outcome,
ApoE genotype of participants will be determined. Buccal
swabs will be taken by making use of Catch-all™ collec-
tion swabs (Epicentre, Madison, Wisc., USA). First, partici-
pants must rinse their mouth thoroughly with water. Then
two swabs are taken from each participant, will be left to
dry for approximately 30 minutes and are frozen until
DNA will be released from the swab by a rapid lysis tech-
nique [57] and the nucleotide sequence will be determined
[58].
Stage of dementia
To assess the stage of dementia of participants, the Dutch
version of the global deterioration scale was used [59]. This
classification scale indicates the severity of the dementia
from pre-dementia stages (1 to 3) to profound (stage 7).
Comorbidity
Comorbid conditions are extracted from the medical sta-
tus and categorized based on the Dutch translation of the
Long-Term Care Facility Resident Assessment Instru-
ment (RAI), section I. This section (disease diagnoses)
includes the following categories: 1) endocrine/metabolic/
nutritional, i.e. diabetes mellitus, hyperthyroidism and
hypothyroidism, 2) heart/circulation, i.e. arteriosclerotic
heart disease, cardiac dysrhythmia, congestive heart fail-
ure, deep vein thrombosis, hypertension, hypotension,
peripheral vascular disease and other cardiovascular dis-
ease, 3) musculoskeletal, i.e. arthritis, hip fracture, miss-
ing limb (e.g. amputation), osteoporosis and pathological
bone fracture, 4) neurological, i.e. AD, aphasia, cerebral
palsy, cerebrovascular accident, dementia other than AD,
hemiplegic/hemi paresis, paraplegia, multiple sclerosis,
Parkinson’s disease, seizure disorder, transient ischemia
attack, traumatic brain injury and quadriplegia, 5)
sensory, i.e. cataracts, diabetic retinopathy, glaucoma and
macular degeneration, 6) psychiatric/mood, i.e. anxiety
disorder, depression, manic depression (bipolar disorder)
and schizophrenia, 7) pulmonary, i.e. asthma and emphy-
sema/chronic obstructive pulmonary disease, 8) other, i.e.
allergies, anaemia, cancer and renal failure.
Medication
Medication use is coded according to the Dutch Pharma-
cotherapeutic Compass and is ranged by the following
groups: 1) sedatives, 2) antipsychotics, 3) antidepressants, 4)
pychotropics (central nervous system (CNS)), 5) neurologi-
cal (CNS), 6) anaesthetics and muscle relaxing, 7) blood, 8)
cardiovascular, 9) gastrointestinal tract, 10) respiratory
tract, 11) kidneys and urinary tract, 12) genital tract, 13)
dermatology, 14) otolaryngology, 15) ophthalmologic, 16)
infectious diseases, 17) hormones and bone metabolism,
18) corticosteroids nonsteroidal anti-inflammatory drugs
(NSAID), 19) corticosteroids nonNSAID, 20) analgesics,
antirheumatic drugs and gout agents, 21) vitamins and
minerals, 22) malignancies, 23) infectious diseases, 24) var-
ious preparations, 25) dentistry, 26) opioids.
Assessment of physical functioning
For all tests of physical functioning, participants wear their
regular footwear and are permitted to use their regular
walking aid. As encouragement has been shown to improve
performance [60], standardized encouragements will be
provided regularly. All tasks are explained and demon-
strated to the participants before testing. No practice trials
are included. Participants perform the tests under continu-
ous supervision of the researcher to prevent the partici-
pants forgetting what they have to do during the tests.
Blood pressure
Systolic blood pressure (SBP) and diastolic blood pressure
(DBP) are measured on the left arm in millimeters of
mercury (mmHg) with an ambulatory blood pressure
monitoring device (model 90207, SpaceLabs Medical Inc.,
Redmond, Washington, USA) while participants are sitting
quietly in a chair for at least 5 minutes [61]. This device is
automated, lightweight, calibrated and validated [62].
Observers do not wear a white-coat to prevent higher
blood pressure measurements due to a white-coat effect
and multiple cuff bladders are used to measure blood
pressure with a cuff bladder that encircles at least 80% of
the arm [61]. In particular, blood pressure of participants
with hypertension, i.e. a higher SBP than 160 mmHg and/
or a higher DBP than 100 mmHg is expected to decrease
during treatment [63]. The SBP and DBP reduction repre-
sents the clinical effectiveness of the treatment [64].
Six minute walk test (6MWT)
The 6MWT can be used reliably in the assessment of
functional endurance ambulation in persons with
acquired brain injury [65]. During the performance of the
6MWT, participants are instructed to cover as much dis-
tance as possible during 6 minutes with the opportunity
to stop and rest if necessary [66]. Participants have to
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walk around a pre-measured, unobstructed 10 by 1 meter
rectangular circuit having semi-circular ends with 0.5
meter radii marked out with plastic cones to prevent par-
ticipants having to walk at sharp angles. One full round
covers 26.3 meters walking. The total walking distance by
each participant will be measured to the nearest meter.
To estimate the effort of participants during the 6MWT
the increase in heart rate will be determined (see heart
rate) [67].
Heart rate
Heart rate at rest is simultaneously measured with blood
pressure. This blood pressure device (see blood pressure)
also measures heart rate in beats per minute. In addition,
heart rate is measured with a pulse oximeter (CMS 60C
TFT color Pulse oximeter) before and directly after the
6MWT for 2 minutes. The faster the heart rate recovers
within 1 minute after the 6MWT the healthier the heart; a
slower heart rate recovery is associated with more severe
coronary artery disease [68].
Oxygen saturation
Arterial oxygen saturation is measured before and directly
after the 6MWT to determine dyspnea [69]. This is mea-
sured with the same pulse oximeter as mentioned above,
simultaneously with heart rate. Oxygen saturation is not
measured during the 6MWT due to motion artefact which
results in unacceptably high failure rates of the devices
[66].
Ten meter timed walk
Participants are requested to walk 10 meters at their own
regular pace between 4 small traffic cones which are
placed in the corners of a 10 by 1 meter rectangle. Their
walk is filmed from behind by a digital video camera
(Panasonic NV-GS330, Matsushita Electric Industrial Co.,
Ltd. Osaka, Japan) standing at least 8 meters behind the
start on an 24.25 inch tripod (Vanguard MK-4). Time to
walk 10 meters is measured by hand with a stopwatch to
the nearest of 1/10 of a second and by video-analysis. By
video-analysis also walking speed measured over 6 meters,
i.e. without the 2 meters at start and 2 meters at finish to
exclude starting hesitation and the slowing down at finish,
step frequency, base width and step length will be
analysed.
Figure of eight
The figure of eight is an applicable and reliable dynamic
functional balance measure of mobility for people with
various degrees of physical disability [70,71] and geriatric
patients [72]. The figure of eight test requires continuous
turning during gait with an emphasis on accuracy (avoid
oversteps), speed (timed task) and switching of motor
patterns during the cross-over from the clockwise to the
counter-clockwise loop. Participants are timed while
walking in a figure-8 trajectory. The figure-8 trajectory is
marked with white paint on a dark green rubber carpet,
each loop having an outer diameter of 165 centimeters
(cm) and a step width of 15 cm. The time to walk two
complete eight figures is measured with a stopwatch. The
onset time is based on the first detectable movement of
the participant following a “Go!” command from the
observer. Any step taken outside the white line is noted.
The fastest attempt of two trials is recorded together
with the corresponding oversteps. Speed (m/s) is 19.792
meter divided by the time in seconds.
Timed up and go (TUG)
The TUG is a reliable and valid test for quantifying func-
tional mobility that may also be useful in following clinical
change over time [73]. To complete the TUG, participants
are requested to rise from a standard chair (48 cm height,
horizontal seat and armrests), walk 3 meters, turn around
and return to a fully seated position in the chair again
[74]. Each participant has two trials and the average time
in seconds is the outcome of the TUG. Scores under
10 seconds are associated with individuals who are func-
tionally independent in the frail elderly population [74].
Sit to stand (STS)
The STS is normally a reliable and valid indicator of lower
body strength in adults over the age of 60 years [75]. How-
ever, in this study participants are allowed to use upper
limbs to rise from the chair to test their rising perfor-
mance that is closest to the clinical setting and to reduce a
floor effect; a high percentage of older dependent elderly
cannot rise from a chair with the arms crossed in front of
the chest [76,77]. Participants are instructed to stand up
and sit down in a standard chair as many times as possible
within 30 seconds. The STS score is formed by the total
number of performances with a sit-stand-sit performance
counting as 1. Ending in a standing position is counted by
a 0.5 point.
Frailty and injuries: cooperative studies of intervention
techniques (FICSIT-4)
The FICSIT-4 is a test to measure static balance [78]. The
participants have to maintain balance in 4 positions with
increasing difficulty. Each position is demonstrated first
and support is offered while participants position their
feet. When participants are ready, the support will be
released and timing begins. The timing stops when partici-
pants move their feet or grasp the researcher for support,
or when 10 seconds have elapsed. Only when one stand is
performed 10 seconds, the next, more difficult stand is
performed. The first stand is with the feet together in par-
allel (side-by-side) position. Second is the semi-tandem
position; the heel of one foot is placed to the side of the
first toe of the other foot. The participant can choose
which foot to place forward. Third is a tandem position;
the heel of one foot directly in front of the toes of the
other foot. The final stand is standing on one leg. The
total summed seconds of all stands is the outcome score.
Volkers and Scherder BMC Geriatrics 2011, 11:38
http://www.biomedcentral.com/1471-2318/11/38
Page 5 of 11
Assessment of cognition
Cognition will be assessed by the following neuropsycho-
logical tests:
Mini-Mental State Examination (MMSE)
The MMSE measures the global level of cognitive func-
tioning [79]. Globally, a score between 25 to 30 indi-
cates no dementia, between 15-24 mild dementia,
between 5-14 moderate to severe dementia and between
0 to 4 profound dementia [80].
Eight words test
The eight words test is a list learning test for people with
memory problems [81]. In this test the examiner reads
out eight words in a row, which is repeated five times.
Every time the participant is asked to recall as many
words as possible. The first outcome measure is the total
number of correctly recalled words after the five trials
(immediate recall score, maximal score = 40). After an
interval of approximately 15 minutes the participant is
asked to recall as many words as possible (delayed recall
score, maximal score = 8). Subsequently, the examiner
reads aloud 16 words among which 8 words presented
before and 8 new words. The participant is asked to
recognize the words from the list presented before (recog-
nition score, maximal score = 16).
Rule shift cards
The rule shift cards is a subtest of the Behavioural Assess-
ment of the dysexecutive Syndrome (BADS) [82]. This
subtest purports mental flexibility and is one of the best
qualifiers to discriminate people with perseverative ten-
dency, i.e. an executive dysfunction, from healthy people
[83]. Participants have to respond to stimuli (red or black
playing cards) according to one of two rules that are pre-
sented consecutively. Performance is scored according to
how successfully the respondent shifts from applying the
first to the second rule [82].
Key search
The key search test is also a subtest of the BADS [82] and
is used to measure how well the participant is able to pre-
pare an efficient plan of action in the context of a routine
event [83]. The patient is asked to imagine that a 100-mm
square on an A4 size paper is a large field, in which they
have lost their keys. They are asked to draw a line, begin-
ning at a black dot, 50 mm below the square, to show the
strategy they would use to search the field, to make abso-
lutely certain that they would find their keys. The test
evaluates a person’s ability to monitor and evaluate their
own performance, taking into account factors that are not
explicitly stated in the instructions. Their search strategy
score is based on a number of criteria, such as efficiency
and effectiveness. The best strategy score is 15 and the
worst score is 2.
Digit span (forward and backward)
The digit span is a subtest from the Wechsler Memory
Scale-Revised (WMS-R) [84]. In the digit span forward,
increasingly long sequences of random numbers are
orally presented at a rate of one digit per second to the
participants, who have to repeat the sequence immedi-
ately after oral representation. In the digit span backward,
participants have to repeat the sequence in reverse order.
To do this, participants perform extra mental operations
on the information that is being held in short term mem-
ory. While the backward condition is often hypothesized
as tapping more into EF than the forward condition
which should measure more short term memory,
research has failed to demonstrate this result [85,86].
These studies suggest that both conditions tap into EF.
Each condition ends when a participant fails to recall at
least two strings of the same length or repeated an eight-
digit sequence correctly. The minimal score for both con-
ditions is 0 and the best score is 21.
Face recognition
Face recognition is a subtest from the Rivermead Beha-
vioral Memory Test (RBMT) [87] and measures visual,
nonverbal long term memory. Two versions (C+D) are
combined to prevent a ceiling effect. In this test the par-
ticipant is shown 10 cards with faces one at a time for 5
seconds. After a short interval of approximately 2 min-
utes, the participant is shown 20 cards, including 10
shown before and 10 cards with new faces. The partici-
pant has to recognise whether the card was shown
before or not. The outcome measure is the number of
faces correctly recognized minus the number of faces
incorrectly recognized. The worst score is -20 and the
best score is +20.
Picture recognition
Picture recognition is also a subtest from the RBMT
[87], which measures visual, verbal long term memory.
Two versions (C+D) are combined to prevent a ceiling
effect. The participant is shown each of the 20 cards
with drawings of objects for 5 seconds. With each card,
the participant is requested to name the object on the
card. After a short interval of approximately 2 minutes,
the participant is shown 40 cards, including 20 shown
before and 20 cards with new objects. The participant
has to recognise whether the card was shown before or
not. The outcome measure is the number of objects cor-
rectly recognized minus the objects that were incorrectly
recognized. The lowest score is -40 and the maximal
score is +40.
Category fluency test
The category fluency test is a verbal fluency test which
can be used to evaluate EF [88,89]. The participant is
asked to name as many examples of a given category as
possible, within 1 minute. This requires a strategic
search mechanism to retrieve information from seman-
tic memory [90]. This study uses the category ‘animals’
and ‘professions’ [91]. The outcome measure is the total
number of animals and professions produced.
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Visual memory span (forward and backward)
The visual memory span is a subtest of the WMS-R [84].
The visual memory span stimuli consist of squares printed
on a two dimensional card and requires the participant to
repeat a number of tapping sequences that becomes
longer with each trial. The visual memory span contains a
forward and a backward sequence, similar to the digit
span test. It was initially added to the WMS-R as a visual
analogue digit span test. The forward condition is used as
a measurement of attention and immediate visual mem-
ory, the backward condition is used as a measure of atten-
tion and visual working memory [84]. Scores range from 0
(worst) to 14 (best) in the forward condition and from 0
(worst) to 12 (best) in the backward condition.
Picture completion
Picture completion is a subtest from the Groninger Intel-
ligence Test (GIT) [92]. The GIT is a test of general intel-
ligence that is used in the Netherlands for purposes
comparable to the Wechsler Adult Intelligence Scale
(WAIS). The picture completion subtest measures visual
perception, specifically, alertness to visual detail [93].
Available literature suggests that this subtest may have
utility as a measure of suboptimal effort, especially in
less-educated participants and is a moderately effective
measure of response bias [93]. Figures are not completely
drawn and participants are instructed to describe the
missing parts of pictured objects. The figures increase in
difficulty. After 20 figures or after 5 false descriptions in
a row, the subtest is finished. The best score is 20, repre-
senting 1 point for every correct description.
Stroop task
The version of the Stroop task that is commonly used in
the Netherlands [94] consists of three subtasks which the
participant performs as quickly as possible; each test has
a 45 second time limit. In the first subtask, participants
are presented with four color words, i.e. red, green, blue
and yellow, printed in black ink in ten rows with ten
names each. The participant’s task is to read as many
color names in the right order. Second, the participant is
presented with a similar paper, but this time with solid
color patches (red, green, blue and yellow) that have to
be named in the right order. In the final subtask the
names of the colors are written in a different color ink
than the meaning of the word (i.e. the word ‘blue’ written
in red ink) and the participants again need to name the
color of the ink, thus suppressing reading the word,
which is a highly automatic reaction. This test has been
found to correlate moderately well with other tests of
response inhibition [95], which is an EF task [96]. The
score on each card is the total correct mentioned colors
within 45 seconds. The final score is the score on card 2
minus the score on card 3. A lower final score indicates a
better performance of inhibition.
Digit symbol substitution test (DSST)
The DSST is a subtest of the WAIS-Revised [84] and has
been widely used as a measure of general information
processing speed in studies of cognitive aging [97]. Test
scores correlate with general intelligence, cognitive
impairment, chronological age and activation in the fron-
tal regions [98-101]. Participants are presented with a
rectangular grid of numbers. For each of these numbers,
participants are instructed to substitute the appropriate
symbol according to a code that appears at the top of the
page. The DSST score is recorded as the number of cor-
rect symbols drawn in 2 minutes.
Assessment of depression level and anxiety
The level of depression and anxiety will be assessed by
the following questionnaires:
Geriatric depression scale (GDS)
The Dutch version [102] of the GDS is a 30-item ques-
tionnaire used to measure general mood [103]. The GDS
is a reliable and valid self-rating depression screening scale
for elderly populations [104]. The GDS questions are
answered by ‘yes’ or ‘no’ depending on which response is
most appropriate at the time of measurement, with 0 or 1
point for each answer. Higher scores indicate a higher
level of depression.
Symptoms checklist 90 (SCL-90)
Two subscales from the Dutch version [105] of the SCL-
90, a 90-item self-report symptom inventory designed to
reflect patterns of current psychological symptoms, will be
used to measure depression and anxiety [106,107]. The
depression and anxiety subscale includes 15 and 10 items
respectively. Each item is rated on a 5-point likert scale,
from 1 (not at all) to 5 (extremely). A higher score indi-
cates more symptoms of depression or anxiety.
Assessment of rest-activity rhythm
Rest-activity data are collected by the use of an Actiwatch
activity monitor (Cambridge Neurotechnology Ltd.,
Cambridge, Great Britain). Actiwatches are small activity
monitors worn on the dominant wrist for several days.
Three variables below are analysed.
Interdaily stability (IS)
The IS serves as a measure to which extent the activity
patterns of all included 24 hour periods resemble each
other. IS is calculated as the ratio between the variance of
the average 24 hours pattern around the mean and the
overall variance [108]. Higher values indicate a more stable
rhythm between days.
Intradaily variability (IV)
The IV quantifies how well the continuity of an arousal
state (sleep/activity) is. Normal rest-activity patterns will
show every 24 hours one major active period (day) and
one major resting period (night) and therefore show a
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low IV. IV is calculated as the ratio of the mean squares of
the difference between successive hours (first derivative)
and the mean squares around the grand mean (overall var-
iance) [108]. Lower values indicate a better rest-activity
pattern.
Relative amplitude (RA)
The RA measures the relative difference in the 10 most
active consecutive hours (M10) and the uninterrupted
least active 5 hours period (L5) within a 24 hours cycle.
RA is calculated as the difference between the means of
M10 and L5 in the average 24 hours pattern [108].
Because it is a relative measure, variance resulting from
differences in sensitivity of actigraphs is reduced. Higher
values indicate a larger difference between daytime activity
and night time rest and therefore a better rhythm.
Assessment of QoL
Qualidem
The Qualidem is a reliable and valid 40-item questionnaire
designed to determine QoL in institutionalized residents
with dementia [109-111]. The questionnaire includes indi-
cative and contra-indicative items that can be divided into
9 homogeneous subscales: 1) care relationship, 2) positive
affect, 3) negative affect, 4) restless tense behaviour,
5) positive self-image, 6) social relations, 7) social isolation,
8) feeling at home, 9) having something to do. The items
are printed in random order, so that items of a subscale
are spread within the questionnaire. Each item has 4 possi-
ble responses; ‘never’, ‘rarely’, ‘sometimes’ and ‘often’. Each
response is scored with 0 to 3 points, with higher scores
indicating higher QoL. The questionnaire is completed by
the nursing staff and varies from the highest QoL (score
120) to the lowest QoL (score 0).
Assessment of ADL
Katz index
The Katz index is a 6-item measure of basic human activ-
ities of daily living: bathing, dressing, toileting, transfer,
continence and feeding [112]. The scale is completed by
the nursing staff and varies from complete independency
(score 6) to maximum dependency (score 18).
Assessment of pain
Pain will be assessed by the following pain scales:
Coloured analogue scale (CAS)
The CAS will be used to determine both pain intensity
and unpleasantness, i.e. affect [113]. The CAS includes 2
pain thermometers which are white at the bottom and red
at the top to measure both aspects of pain. It was origin-
ally developed to measure pain in young children, but it
has also been used in elderly with dementia [114]. The
psychometric properties of CAS are comparable to those
of visual analogue scales [113]. Participants are instructed
to rate both the pain intensity and the unpleasantness of
the pain from which they suffer at that moment. On the
back of the thermometers a value is given to the pain
aspects from 0 (no pain/no affect) to 10 (highest pain
intensity/highest affect).
Faces pain scale (FPS)
The FPS is an instrument to assess the severity of pain
on a scale with 7 faces, ranked in order of pain [115].
The participant’s score corresponds to the scale number,
ranging from 0 (neutral face) to 6 (extreme painful face).
It was originally developed to measure pain in young
children, but the FPS has also been used in elderly peo-
ple with dementia [114].
Statistical analysis
Comparability between the intervention group and the
control group will be assessed at baseline to check for
differences between the groups on characteristics that
may influence the results on the outcome variables.
Scores on neuropsychological tests will be converted
into z scores and, according to factor analysis, summed
up to form specific cognitive domains. A two-way
repeated measurement design (T1-T6), with time as
within group factor and group (intervention vs control)
as between group variable, will be used to analyse the
effect of the intervention on the outcome variables.
Discussion
This paper presents the design of a RCT, which aims to
explore the longitudinal effect of regular walking on sev-
eral health aspects of older people with dementia. The
strength of this study is that 1) the intervention is not
performed by the research staff, but by the nursing staff
which enables it to become a routine in usual care, 2)
we have a high number of repeated measurements, i.e.
one baseline and 6 post measurements, 3) the various
outcome variables enables us to analyse the develop-
ment of different health aspects within 18 months.
Possible limitations of this study are that 1) only active
minded institutions are willing to participate creating a
selection bias, 2) there will be a (high) drop-out rate, for
example due to death, 3) not all participants will be able
to perform/understand all tests.
This method is appropriate to collect data on the effec-
tiveness and feasibility of a walking program. It is also
interesting to examine what aspects determine the com-
pliance of the participants. Due to the aging and demen-
tia process, it is not always necessary to increase in test
score to find an effect of the intervention, but stabilizing
cognitive and behavioural functioning in those who parti-
cipate in the walking group would also be worthwhile.
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